Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromes.

Huang WT, Yang X, Zhou X, Monzon FA, Wen J, Hagenkord JM, Wu LY, Keever-Taylor C, Novoa-Takara L, Wong ST, Young K, Chang CC.

Leuk Res. 2009 Jun;33(6):847-53. doi: 10.1016/j.leukres.2008.10.008. Epub 2008 Dec 11.

PMID:
19084271
2.

Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.

Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J.

Int J Lab Hematol. 2015 Apr;37(2):181-9. doi: 10.1111/ijlh.12257. Epub 2014 May 21.

PMID:
24845343
3.

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.

Svobodova K, Zemanova Z, Lhotska H, Novakova M, Podskalska L, Belickova M, Brezinova J, Sarova I, Izakova S, Lizcova L, Berkova A, Siskova M, Jonasova A, Cermak J, Michalova K.

Leuk Res. 2016 Mar;42:7-12. doi: 10.1016/j.leukres.2016.01.009. Epub 2016 Jan 24.

PMID:
26851439
4.

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP.

Blood. 2008 Feb 1;111(3):1534-42. Epub 2007 Oct 22.

5.

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.

Mohamedali A, Gäken J, Twine NA, Ingram W, Westwood N, Lea NC, Hayden J, Donaldson N, Aul C, Gattermann N, Giagounidis A, Germing U, List AF, Mufti GJ.

Blood. 2007 Nov 1;110(9):3365-73. Epub 2007 Jul 18.

6.

Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.

Gondek LP, Haddad AS, O'Keefe CL, Tiu R, Wlodarski MW, Sekeres MA, Theil KS, Maciejewski JP.

Exp Hematol. 2007 Nov;35(11):1728-38. Epub 2007 Oct 17.

PMID:
17920760
7.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.

Merkerova MD, Bystricka D, Belickova M, Krejcik Z, Zemanova Z, Polak J, Hajkova H, Brezinova J, Michalova K, Cermak J.

Genes Chromosomes Cancer. 2012 May;51(5):419-28. doi: 10.1002/gcc.21927. Epub 2012 Jan 17.

PMID:
22250017
8.

SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.

Gondek LP, Dunbar AJ, Szpurka H, McDevitt MA, Maciejewski JP.

PLoS One. 2007 Nov 21;2(11):e1225.

9.

Clonality in myelodysplastic syndromes.

Weimar IS, Bourhis JH, De Gast GC, Gerritsen WR.

Leuk Lymphoma. 1994 Apr;13(3-4):215-21. Review.

PMID:
7914126
10.
11.
12.

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.

Heinrichs S, Kulkarni RV, Bueso-Ramos CE, Levine RL, Loh ML, Li C, Neuberg D, Kornblau SM, Issa JP, Gilliland DG, Garcia-Manero G, Kantarjian HM, Estey EH, Look AT.

Leukemia. 2009 Sep;23(9):1605-13. doi: 10.1038/leu.2009.82. Epub 2009 Apr 23.

13.

Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.

Kibbelaar RE, van Kamp H, Dreef EJ, de Groot-Swings G, Kluin-Nelemans JC, Beverstock GC, Fibbe WE, Kluin PM.

Blood. 1992 Apr 1;79(7):1823-8.

14.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
15.

Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.

Nowak D, Nolte F, Mossner M, Nowak V, Baldus CD, Hopfer O, Noll S, Thiel E, Wagner F, Hofmann WK.

Exp Hematol. 2009 Feb;37(2):215-224. doi: 10.1016/j.exphem.2008.10.012.

PMID:
19135900
16.

Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.

Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.

Acta Paediatr. 2004 Aug;93(8):1015-23. Review.

PMID:
15456186
17.

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

Mehrotra B, George TI, Kavanau K, Avet-Loiseau H, Moore D 2nd, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG.

Blood. 1995 Aug 1;86(3):1139-47.

18.

250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.

Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP.

Cancer Res. 2008 Dec 15;68(24):10349-57. doi: 10.1158/0008-5472.CAN-08-2754.

19.

Physician Education: Myelodysplastic Syndrome.

Yoshida Y.

Oncologist. 1996;1(4):284-287.

20.

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP.

Blood. 2011 Jun 23;117(25):6876-84. doi: 10.1182/blood-2010-11-314393. Epub 2011 Apr 28.

Supplemental Content

Support Center